Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylaxis and Treatment of COVID-19 - Adaptive Platform Trial

NCT04844541 is registered in ClinicalTrials.gov with Henry M. Jackson Foundation for the Advancement of Military Medicine as lead sponsor.

NCT NCT04844541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04844541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylaxis and Treatment of COVID-19 - Adaptive Platform Trial
Lead sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase
Observational
Overall status
Completed
Start date
June 11, 2021
Completion date
February 21, 2024
Enrollment
450 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory infection, covid-19